Cellular immune responses have been shown to play an important role in determining the outcome of virus infection in several experimental models (1, 2) . Among the manifestations of cellular immunity in viral infection the capacity of specifically sensitized thymus-derived (T) 1 lymphocytes to destroy virus-infected target cells in vitro has been demonstrated to correlate with elimination of infectious virus in vivo (3, 4) and hence suggests a direct role for cytotoxic T lymphocytes (CTL) in recovery from virus infection. Since the functional activity of CTL raised against viruses (5) (6) (7) (8) as well as minor histocompatibility antigens (9, 10) and chemically modified cells (11) has also been shown to be under the control of genes in the major histocompatibility complex (MHC), the specificity of CTL for both the gene products of the MHC and the foreign determinant on target cell surfaces has been analyzed in great detail. On the other hand, much less information is presently available on the requirements for induction of virus-specific CTL. An issue which is presently controversial is the requirement for infectious virus in the induction of virusspecific CTL. Several laboratories have reported that CTL responses to a diverse group of viruses can be readily stimulated with inactivated virion preparations (12) (13) (14) (15) , whereas infectious virus is required for CTL induction in other hands (16) . Also inactivated virus (12, 13) or indeed virion subunit preparations (17) have been reported to sensitize target cells for CTL-mediated lysis in the absence of nascent viral protein in the target cell (12, 17) , whereas infectious virus and nascent viral protein synthesis is required for lysis of target cells in other circumstances (18) . The resolution of this issue would appear to have direct implications with respect to viral vaccines, particularly in assessing the efficacy of live virus and killed virus vaccines. Furthermore, an understanding of the role of viral infectivity both in the induction of CTL and target cell sensitization may be of value in understanding the mechanism of CTL recognition.
This report examines the capacity of infectious and inactivated influenza virus to stimulate virus-specific CTL responses in vivo and in vitro. We have observed that while infectious influenza virus was capable of stimulating both CTL responses and humoral immune responses in vivo over a broad immunizing dose range, ultra-violet inactivated influenza virus neither induced CTL responses in vivo nor sensitized putative target cells for lysis by influenza-specific CTL in spite of its capacity to stimulate a comparable in vivo humoral immune response. Inactivated influenza virus could, however, stimulate a CTL response in vitro. These results are discussed in the light of the observations outlined above. Possible implications for virus-specific CTL induction are also considered.
Materials
and Methods General. Male BALB/C mice (7-12 wk of age) bred at the John Curtin School were used throughout. P815 mastocytoma cells, maintained in tissue culture, were used as target cells in all experiments (19) . Eagle's minimal essential medium (Grand Island Biological Co., Grand Island, N.Y. catalogue no. F-15), supplemented with 10% heat-inactivated fetal calf serum (Commonwealth Serum Laboratories, Melbourne, Australia) was used as the medium in all cytotoxicity assay.
Viruses. Influenza virus strains A/WSN (H0/N1), A/JAP/305 (H2/N2), and B/LEE were grown in the allantoic cavity of embryonated eggs and stored as infectious allantoic fluid as described previously (19) .
Virus Purification and Inactivation. Before inactivation, virus, as infectious allantoic fluid, was concentrated and purified according to standard procedures (20) . Influenza A]WSN was concentrated by adsorption-elution from fowl erythrocytes followed by ultracentrifugation. Influenza A/JAP was similarly concentrated and further purified by velocity centrifugation over sucrose gradients (20) . Purified virus was diluted to a concentration of 105 hemagglutination units (HAU)/ml in sterile phosphate-buffered saline (PBS) and exposed to a 25-watt ultraviolet (UV) light source at a distance of 20 cm for 7 min in 9 cm glass Petri dishes containing 5-6 ml of virus suspension. The virus suspension was stirred constantly during exposure to the UV source. The infectious viruses had a titer of 5 × 108 -109 EIDso U/ml and 1.5-3.0 x 10 a HAU/ml. Egg infectivity titers were determined by the modified Spearman-K/iber method (21) . Hemagglutination titrations were performed according to Fazekas de St. Groth and Webster (22) . No residual infectious virus was detectable in inactivated virus preparations as measured by egg infectivity. No loss of viral hemagglutinating activity was observed after virus inactivation. Inactivated virus was stored at 4°C.
Immunization. Mice were inoculated with virus by the intravenous route. Infectious virus, as allantoic fluid was diluted in PBS and administered in quantities as indicated in the text. UVinactivated virus was administered in a similar fashion. For in vivo primary cytotoxic responses, spleens from three donor mice were removed 6 days after immunization and a spleen cell suspension was prepared as previously described (8) . For in vivo secondary responses, mice primed previously with 100 HAU of infectious virus were inoculated 3-4 wk later with infectious or inactivated virus as indicated in the text. 5 days later spleens from three donors were removed and processed as above. For adoptive in vivo secondary responses 80-100 × l0 s spleen cells from donors primed 3-4 wk previously with infectious virus were transferred intravenously into age and sex matched recipient mice which had received 450 rads of total body v-irradiation from a radioactive cobalt source. Recipient mice were inoculated with virus immediately after cell transfer. Recipient spleens were removed 5 days later and tested for cytotoxicity.
In Vitro Secondary Responses. Cytotoxic T lymphocytes were generated in vitro essentially as described previously (8, 19) . Briefly, 40 x 106 spleen cells from mice primed 3-8 wk previously with 100 HAU of infectious influenza virus were cultured with "stimulator" cells in 25 cm 2 Falcon tissue culture flasks (Becton, Dickinson and Co., Oxnard, Calif.) containing 15 ml of medium (8, 19) . The responder cell to stimulator cell ratio was 10:1. Stimulator cells consisted of normal syngeneic spleen cells either infected with 5 EIDso U of infectious virus per nucleated cell (60 HAU of infectious virus per 4 × l0 s cells) or treated with various quantities of inactivated influenza virus in an identical fashion. Stimulator cells were washed twice before culturing with responder cells to remove unadsorbed virus. Viable cells were tested for cytotoxic activity after 5 days of culture. Recovery of viable cells was 20-40% at that time.
Assay for Cell-Mediated Cytotoxicity. The 51Cr release cytotoxicity assay was carried out as described in previous reports (8, 19) . 51Cr-labeled P815 target cells were infected in suspension with 10 EIDs0 U of infectious virus per cell (30 HAU of infectious virus per 105 target cells) as described (19) . Target cells were treated with various quantities of UV-inactivated influenza virus in an identical fashion. Unless otherwise indicated in the text, assay times were 8-8.5 h for primary effector activity and 6.5 h for secondary effectors. Spontaneous ~Cr release from target cells incubated with medium only usually ranged'from 5 to 15% and was always less than 18%. Percent specific slCr release was obtained from the formula:
test counts -spontaneous release × 100. water lysis counts -spontaneous release All values represent the mean percent specific 5~Cr release of four replicate wells.
Assay for Anti-Hemagglutinin Antibody. Serum anti-hemagglutinin antibody was quantitated by the microtitration hemagglutination inhibition test (23) . 4 HAU of virus in a vol 0.025 ml were added to serial twofold dilutions of serum in a final vol of 0.025 ml of PBS. After 35 rain of incubation, 0.025 ml of a 1% suspension of fowl erythrocytes was added to each well. After 30 rain of incubation, the hemagglutination-inhibition endpoint was determined. All sera were treated with Vibrio cholera receptor-destroying enzyme (Center for Disease Control, Atlanta,Ga.) and heated to 56°C for 30 rain to remove nonspecific inhibitors. Preimmune sera from immune sera donors served as controls.
Results
In a series of preliminary experiments the capacity of influenza virus strain A/WSN to induce CTL was assessed after inactivation of the virus by several different methods. In contrast to results obtained with infectious influenza virus (8, 19) no influenza-specific CTL activity was detectable in the spleens of mice after intravenous inoculation of A/WSN virus inactivated either by UV irradiation, sodium deoxycholate disruption, or heat treatment (data not shown). Because UV irradiation was considered to have the least detrimental effect on both virion architecture and viral antigen stability, this method of virus inactivation was used in subsequent experiments.
Antigen Dose Dependence of the in Vivo Primary CTL Response to Infectious Influenza Virus. Fig. 1 shows the cytotoxic response from the spleens of mice 6 days after administration of the indicated doses of infectious influenza A/ WSN. Cytotoxic activity was detectable with infectious virus doses as low as 10 -3 HAU (102 EIDso U). The magnitude of lytic activity was directly proportional to the concentration of infectious virus in the immunizing inoculum over a range of antigen doses. This direct relationship between immunizing virus dose and splenic CTL activity was consistently observed in a series of experiments. An analysis of the kinetics of the cytotoxic response (not shown) indicated that as demonstrated previously (8, 19, 24) optimal cytotoxic activity was maximum at 5-7 days postinoculation. Thus, the difference in magnitude of the cytotoxic response with different virus doses was not attributable to differences in the kinetics of appearance of cytotoxic activity. The T-cell origin of the cytotoxic cell activity has been demonstrated previously (8, 19) .
Absence of an in Vivo Primary CTL Response with UV-Inactivated Influenza Virus. Table I not generate a significant CTL response in vivo with virus doses as high as 104 HAU. The low level of cytotoxicity observed in the assay at the highest effector to target ratio is comparable to the background cytotoxicity observable with normal spleen cells and probably does not reflect low level specific cytotoxic activity. Spleens from mice immunized with l0 s HAU of inactivated virus were also examined for CTL activity at 2-day intervals up to 10 days after immunization. No cytotoxic activity was detectable during this period at a time when optimal CTL responses are detectable in a variety of diverse viral systems (25) . Although these results were obtained with influenza strain A/WSN, we have obtained similar results with two other influenza strains: A/JAP/305 (H2N2) and B/LEE.
Humoral Immune Response to Infectious and Inactivated Influenza Virus. Since the above results indicated a marked disparity between infectious and UV-inactivated virus in their respective capacities to induce CTL responses in vivo, the humoral immune response to various doses of these virus prepartions was examined (Table II) . Both virus preparations induced significant levels of anti-viral antibody as measured by hemagglutination inhibition. Likewise for both virus preparations the magnitude of the response was proportional to the immunizing antigen dose. Although the humoral response to infectious virus was greater at lower immunizing doses, similar antibody levels were achieved upon immunization with higher doses of UV-inactivated virus, i.e., 102-104 HAU.
Absence of an in Vivo Secondary CTL Response on Challenge with Inactivated Influenza Virus. Secondary CTL responses to infectious influenza virus have been demonstrated both in vivo (24) and in vitro (8, 19) after primary immunization with infectious influenza virus. Since the above results indicated that UV-inactivated influenza was a poor stimulator of a primary CTL response, (Table III) . In no instance did the cytotoxic activity of spleen cells from mice receiving secondary challenge with inactivated influenza virus exceed the background cytotoxicity of cells from control mice. On the other hand, spleen cells from mice previously primed with infectious A/WSN virus showed significant cytotoxic activity on both A/WSN and A/JAP infected target cells when secondarily stimulated with infectious A/JAP virus (Table III) .
INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T CELLS

Generation of an in Vitro Secondary Response to Inactivated Influenza Virus. Although the above results would indicate that inactivated influenza
is also an inefficient stimulator of secondary CTL responses, the presence of circulating anti-viral antibody in the primed recipients could alter the secondary CTL response upon challenge with inactivated virus. Indeed, it has been demonstrated that poor secondary CTL responses are observed when mice, previously primed with a given infectious type A influenza strain are challenged with the homologous infectious virus (24) , whereas secondary stimulation with an infectious type A influenza strain of a different subtype generates good CTL responses in the primed recipients (Table III and [24] ). This poor cytotoxic T-cell response on secondary stimulation with homologous virus appears to be due to After 5 days of culture, the cytotoxic activity of the responder cells was examined. $ As in Table III. § As in Table I Table I . II Values are the means ± standard errors of the mean from four wells with spontaneous release substracted.
tions prompted a re-examination of the capacity of UV-inactivated virus to stimulate in vivo secondary CTL responses under conditions where circulating anti-viral antibody was eliminated. This situation was achieved by adoptive transfer of spleen cells from mice primed with infectious A/WSN or A/JAP viruses into sublethally irradiated syngeneic recipients. Recipient mice were then challenged with either inactivated A/WSN, inactivated A/JAP, or the infectious homologous virus used in primary immunization.
5 days later, the spleens of these recipients were examined for cytotoxic activity (Table V) circulating anti-viral antibody, a potent CTL response can be obtained on secondary stimulatibn with homologous infectious virus. However, neither homologous virus nor heterologous type A influenza virus, when inactivated, stimulated a cytotoxic response under these conditions.
Lack of Target Cell Sensitization with Inactivated Influenza Virus.
Several laboratories have reported that treatment of uninfected cells with inactivated paramyxoviruses (12, 13) or paramyxovirus subviral components (17) rendered these cells susceptible to specific lysis by cytotoxic T cells directed to these viruses. Because of the disparity between the in vivo and in vitro results described above, it was of interest to determine if inactivated influenza virus could sensitize putative target cells for lysis by influenza specific CTL in vitro. ~lCr-labeled uninfected P815 mastocytoma cells were incubated under standard conditions (see Materials and Methods) with infectious A/WSN, A/JAP, or B/ LEE viruses or with various concentrations of UV-inactivated A/WSN or A/ JAP viruses and exposed in a standard cytotoxicity assay to highly potent influenza A/JAP-specific secondary effectors generated in vitro (Table VI) . As demonstrated previously (Table IV and [19] ), target cells infected with either A/ WSN or A/JAP infectious virus were highly susceptible to lysis by these effector cells. On the other hand, target cells treated with inactivated A/WSN or A/JAP at concentrations up to 200-fold higher than the concentration of infectious virus needed to sensitize target cells, showed no lysis above background observed on B/LEE-infected or uninfected target cells. Identical results were obtained with secondary effectors specific for influenza A/WSN (not shown). The high degree of background lysis demonstrable on influenza B/LEE-infected or uninfected target cells has been previously observed with virus-specific cytotoxic T cells generated in vitro (3, 8) and was somewhat magnified by the relatively high effector to target ratio (5:1) and the longer incubation time (8 h) employed in the assay. These assay conditions were chosen to increase the possibility of detecting sensitization of target cells by inactivated virus.
Discussion
In this report, we have examined the issue of whether infectious virus is necessary both for the induction of CTL responses (i.e., stimulator cell sensitization) and for target cell sensitization or alternatively, whether induction and target cell sensitization can be achieved with noninfectious virus preparations. We have observed that while infectious influenza virus was highly efficient at inducing both primary and secondary influenza-specific CTL responses, noninfectious (UV-inactivated) influenza virus failed to stimulate detectable primary or secondary CTL responses in vivo. Similarly, noninfectious virus failed to sensitize target cells for lysis by influenza-specific cytotoxic T cells in vitro. However, inactivated virus could stimulate an influenza-specific secondary CTL response in vitro.
Before considering possible interpretations and implications of these results, two critical issues pertinent to our in vivo observations must be considered. The first issue is whether the inactivation procedure itself rendered the virus immunologically inactive. This possibility is unlikely since inactivated virus was capable of stimulating an adequate humoral immune response in vivo and could in vitro stimulate a specific cell-mediated cytotoxic response. The second issue is whether the parenteral administration of infectious influenza virus generates a sufficient antigen dose, as a result of replication in vivo, to induce a CTL response, whereas noninfectious (inactivated) virus fails to achieve such stimulatory antigen concentrations. We have attempted to approach this issue by examining the antigen dose dependence of CTL generation with both infectious and inactivated virus. Although low doses of infectious influenza virus (10-2-10 -2 HAU) induced detectable cytotoxic T-cell responses in vivo, no specific cytotoxic activity was detectable in vivo with 105-106-fold higher concentrations of inactivated virus (Fig. 1, Table I ). Furthermore, since the humoral immune response to both infectious and inactivated virus was proportional to the immunizing virus dose and similar in magnitude, it is unlikely that extensive virus replication occurs in vivo after intravenous inoculation of infectious influenza virus. Also, current evidence indicates that the relevant target organs, presumably involved in the clearance of the parenterally administered virus inoculum (e.g., liver, spleen, lymph nodes), are not productively infected with influenza virus (26, 27) . Taken together, these observations suggest that the difference between infectious and noninfectious influenza viruses in their respective capacities induce CTL responses in vivo is not purely a function of antigen dose in vivo.
A number of laboratories have recently reported results different from those reported here (12) (13) (14) (15) 17) . The results which are perhaps most germane to the present discussion involve the paramyxovirus model where inactivated virus preparations have been shown to both induce virus-specific CTL responses (12, 13) and sensitize target cells for T-cell-mediated lysis in vitro (12, 13, 17) . The difference between these observations and those reported here, we believe, lies in the fact that the paramyxovirus virion possesses a specific fusion protein (28) which allows for the efficient integration of virion surface antigens into the cell cytoplasmic membrane (28) and also promotes cell-to-cell fusion (29) . Such fusion activity has not been demonstrated in influenza viruses (29, 30) . Furthermore, it has been recently reported that a functionally active fusion protein is necessary for the sensitization of target cells by a UV-inactivated paramyxovirus (31) . In the light of these findings and our inability to sensitize target cells with inactivated influenza viruses (Table VI) , we propose that both for the induction of virus-specific CTL responses and for the expression of the effector activity of CTL, the relevant viral antigens must be presented on the surface of the putative stimulator or target cell as integral membrane components, i.e., inserted into the membrane lipid bilayer. Such a situation could be readily achieved either by direct integration of the virion antigens into the cell membrane through fusion, as in the case of paramyxoviruses and other viruses which possess efficient fusion capacity or as exemplified by viruses such as influenza, which lack such efficient fusion activity, by incorporation of nascent antigens into the cell membrane during the course of virus infection. Although our results on the induction of CTL responses in vivo and target cell sensitization in vitro with inactivated influenza virus are consistent with the above hypothesis, the induction of a secondary cytotoxic response to inactivated virus in vitro is in apparent disagreement. This result is open to two interpretations: first, it is possible that there is a qualitative difference in the requirements for CTL induction under in vitro conditions of stimulation, i.e., precursors of cytotoxic T cells can be directly stimulated by free virus or virus adsorbed to the stimulator cell surface in vitro but not in vivo. Second, it is possible that this difference is quantitative, i.e., inactivated influenza virus is capable of sensitizing stimulator cells by integration of virion antigens into the cell cytoplasmic membrane but with an efficiency too low to be detectable either at the level of target cell sensitization in vitro or under in vivo conditions of stimulation. In vitro conditions of stimulation, on the other hand, would favor the detection of a response to the small number of sensitized stimulator cells generated by inactivated virus. A resolution of this point may come from experiments with purified influenza virus antigens which have recently been shown to stimulate a specific CTL response from primed cells in vitro (32) . 2 Such studies are now in progress.
At least two distinct subpopulations of cytotoxic T cells are generated in response to infectious type A influenza virus (19, 24) , one of which is specific for the immunizing virus strain (virus-strain-specific), the other of which exhibits a high degree of crossreactivity for target cells infected with type A influenza viruses of any subtype (19, 24, 33) . Current evidence suggests that the target antigens for these two cytotoxic subpopulations are the influenza virion surface glycoproteins (hemagglutinin and possibly neuraminidase) and the internal virion antigen matrix protein, respectively (34) . Since inactivated influenza A/ JAP stimulated a cytotoxic response which was specific for A/JAP targets (Table IV) , only the virus-strain-specific CTL subpopulation appears to have been generated in response to this virus preparation. 3 This result implies that the in vitro response to inactivated A/JAP virus was not due to a low level of infectious virus in the virion preparation since infectious A/JAP virus also stimulates a response in the crossreactive cytotoxic subpopulation (Table IV) . Zweerink et al. (32) , however, have recently reported the induction of a CTL response to UV-inactivated influenza virus which was highly cross-reactive. The most likely cause for the discrepancy between our results and those of Zweerink et al. is the difference in the extent of virus inactivation: 7 min vs. 1 min UV exposure, respectively. Since the infectivity of an influenza virus preparation is lost more rapidly during inactivation than the capacity of the virions to direct the synthesis of specific viral antigens (35) , it is possible that a partially inactivated virus preparation, although incapable of producing infectious virions, is capable of directing the synthesis and expression of relevant viral antigens on the stimulator cell surface during an abortive cycle of replication. Consistent with this concept is the observation that the putative target antigen for cross-reactive cytotoxic subpopulation, influenza matrix protein (34) is expressed on the cell surface during the course of infection (34, 36, 37) but is internally located in the influenza virion (30) . Two other reports of CTL responses to inactivated virus (14, 15) might be explained on a similar basis, i.e., synthesis and expression of the relevant viral antigens in the absence of infectious virus production. Since, in these reports, the capacity of inactivated virus to sensitize target cells or to direct nascent viral protein synthesis was not examined, the discrepancy between these observations and those reported here, remains to be resolved.
An observation reported here which warrants further discussion is the capacity of inactivated influenza virus to stimulate an in vivo primary humoral immune response in the absence of a detectable CTL response in vivo. Since the induction of an in vivo primary humoral immune response to influenza virus has been shown to be thymus-dependent (38) (39) (40) , it is likely that helper T cells can be activated by either infectious or inactivated influenza virus in vivo. However, only infectious virus stimulates a detectable CTL response in vivo. One possible interpretation of this observation is that helper T cells and cytotoxic T-cell precursors differ in their requirements for induction with respect to mode of antigen presentation. According to the hypothesis outlined above, the induction of a CTL response to specific viral antigens would require their presentation on the stimulator cell as integral membrane components, whereas the activation of helper T cells directed to these antigens could be achieved in a manner analogous to that suggested for soluble antigens (41) . In this connection, it should be noted that precursors of helper T cells and precursors of cytotoxic T cells also differ in their requirements for induction By using appropriate recombinant influenza virus strains, the specificity of the cytotoxic cells for influenza A/JAP hemagglutinin has been demonstrated (T. J. Braciale, unpublished observations).
with respect to genes in the MHC (42) (43) (44) . The question of whether this genetic difference in the requirement for helper and cytotoxic T-cell induction is a reflection of the difference in the mode of antigen presentation will require further analysis of these two T-cell subsets.
The requirement for viral infectivity in the induction of virus-specific cytotoxic T cells remains to be fully elucidated. Factors which should be considered in assessing this requirement include: (a) whether the virus employed has efficient fusion activity which could promote efficient integration of virion antigens into the cell cytoplasmic membrane; (b) whether an inactivated virus preparation which fails to undergo a complete cycle of replication, i.e., produce infectious virus, is also incapable of inducing nascent viral protein synthesis during an abortive cycle of replication; (c) whether the analysis is undertaken in vivo or in vitro. Based on our own observations and those of other investigators we have proposed that both the induction of virus-specific cytotoxic T cells and the expression of their lytic activity requires the presentation of the relevant viral antigens on the surface of the stimulator or target cell as integral membrane components. Experiments are now in progress to test this proposal.
Summary
This report examines the requirement for infectious virus in the induction of influenza virus-specific cytotoxic T cells. Infectious influenza virus was found to be highly efficient at generating both primary and secondary cytotoxic T-cell response in vivo. Inactivated influenza virus however, failed to stimulate a detectable cytotoxic T-cell response in vivo even at immunizing doses 105-10 efold higher than the minimum stimulatory dose of infectious virus. Likewise inactivated virus failed to sensitize target cells for T-cell-mediated lysis in vitro but could stimulate a specific cytotoxic response from primed cells in vitro. Possible requirements for the induction of virus-specific cytotoxic T-cell responses are discussed in light of these observations and those of other investigators.
